Biotechnologies



Sort by : relevance - date - popularity
1Vote!

scientists identify genetic factors that hold promise for treatment of vascular diseases

[NEWS] Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) have discovered a key switch that makes stem cells turn into the type of muscle cells that reside in the wall of blood vessels. The same switch might be used in the future to limit growth of vascular muscle cells that cause narrowing of arteries leading to heart attacks and strokes, limit formation of blood vessels that...

+Vote!

Pitt team finds molecule that regulates heart size by using zebrafish screening model

[NEWS] Using zebrafish, researchers at the University of Pittsburgh have identified and described an enzyme inhibitor that allows them to increase the number of cardiac progenitor cells and therefore influence the size of the developing heart. The findings are described in the advance online version of Nature Chemical Biology. The zebrafish model has powerful advantages for studying embryonic development,...

1Vote!

Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis

[NEWS] Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc. (NYSE-AMEX: NBY), announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay's patented lead Aganocide® compound, NVC-422, for viral conjunctivitis, a type of “pink eye”. Conjunctivitis is…

1Vote!

Rare sheep could be key to better diagnostic tests in developing world

[NEWS] The newest revolution in microbiology testing walks on four legs and says “baa.” It's the hair sheep, a less-hirsute version of the familiar woolly barnyard resident. A new study from the Stanford University School of Medicine, which is to be published July 3 in PLoS ONE, finds that not only are these ruminants low-maintenance and parasite-resistant, they're also perfect blood donors...

1Vote!

Perfect pitch study offers window into influences of nature and nurture

[NEWS] Practice, practice, practice might get you to Carnegie Hall, but for aspiring musicians, there's new evidence that genes may influence one's ability to get there, as well. Perfect pitch, also known as absolute pitch, is the rare ability to recognize and name musical notes without any reference pitch for comparison, detecting, for instance, A before middle C. The rarity of the aptitude contrasts...

1Vote!

Genentech drug does well in eye test

Genentech Inc. said a Phase III study of Lucentis in patients with swelling of the eye caused by branch retinal vein occlusion — a common cause of blindness — showed that the drug improved vision.

+Vote!

Biogen Idec to Report Second Quarter 2009 Financial Results on July 16, 2009

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report second quarter 2009 financial results on Thursday, July 16, 2009, before the financial markets open.

1Vote!

Secrets revealed about how disease-causing DNA mutations occur

[NEWS] A team of Penn State scientists has shed light on the processes that lead to certain human DNA mutations that are implicated in hundreds of inherited diseases such as tuberous sclerosis and neurofibromatosis type 1. The results one day could influence the way couples who seek to have children receive genetic counseling. The team, led by Kateryna Makova, an associate professor of biology, also...

+Vote!

Researchers reveal connection between cancer and human evolution

[NEWS] Mutational patterns in mitochondrial genomes show functional importance of evolution and disease BEER-SHEVA, ISRAEL, July 2, 2009 – Researchers at Ben-Gurion University of the Negev (BGU) have discovered that gene mutations that once helped humans survive may increase the possibility for diseases, including cancer. The findings were recently the cover story in the journal Genome Research....

+Vote!

Research output in developing countries reveals 194 percent increase in five years

[NEWS] The partners of Research4Life announced today at the World Conference of Science Journalists 2009 that a new research impact analysis has demonstrated a dramatic rise in research output by scientists in the developing world since 2002. By comparing absolute growth in published research before (1996 – 2002) and after (2002 - 2008) the advent of the Research4Life programmes, the analysis...

+Vote!

avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign

LUMBY, BC /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the engagement of Koeppel Direct to manage their direct response media buying.Lorie Campbell-Farley, President/COO of avVaa World Health Care is excited to be associated...

+Vote!

Lixte Biotechnology Holdings' Lead Compound, LB-1.2, Enhances the Effectiveness of Standard Cancer Chemotherapy in Animal Models

EAST SETAUKET, N.Y., July 2 /PRNewswire-FirstCall/ -- Lixte Biotechnology Holdings (OTC Bulletin Board: LIXT) announced today that investigators of the National Institute of Neurological Disorders and Stroke (NINDS) and the National Cancer Institute (NCI), National Institutes of Health and Lixte reported that its novel compound, LB-1.2, enhances the effectiveness of two standard chemotherapy drugs...

+Vote!

Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.K. Phase I/II REOLYSIN paclitaxel and carboplatin trial and the Company's belief as to the potential of REOLYSIN as a cancer therapeutic, involve known and unknown risks and uncertainties,...

1Vote!

WuXi PharmaTech Receives Award from BASF

WuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, we provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. Our services are designed to help our global partners...

1Vote!

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

[NEWS] REYKJAVIK, Iceland, July 1 /PRNewswire-FirstCall/ — The largest study of the genetics of schizophrenia ever undertaken has revealed several new common single-letter variants in the sequence of the human genome (SNPs) linked to risk of the disease. The study, by a multinational consortium of scientists led by a team from deCODE genetics (Nasdaq: DCGN), analyzed the genomes of more than...